Lower genital tract intraepithelial neoplasia in HIV-infected women: Guidelines for evaluation and management

Obstetrical and Gynecological Survey

Volumn 54, Issue 2, 1999, Pages 131-137

  Spitzer, Mark ^a  

^a QUEENS HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CYTODIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PAPANICOLAOU TEST; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; FEMALE; HIV SEROPOSITIVITY; HUMANS; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS;

EID: 0032918638     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199902000-00023     Document Type: Review

References (51)

1. Centers for Disease Control and Prevention. Acquired immunodeficiency syndrome, 1992. Morb Mortal Wkly Rep 1993; 42:547-557.
2. Zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.
3. Wright TC, Richart RM. Role of human papillomavirus in the pathogenesis of genital tract warts and cancer. Gynecol Oncol 1990;37:151-164.
4. Bornstein J, Rahat MA, Abramovici H. Etiology of cervical cancer: Current concepts. Obstet Gynecol Surv 1995;50:146-154.
5. Spitzer M, Brennessel D, Seltzer VL et al. Is human papillomavirus-related disease an independent risk factor for human immunodeficiency virus infection? Gynecol Oncol 1993;49: 243-246.
6. Maiman M, Fruchter RG, Serur E et al. Prevalence of human immunodeficiency virus in a colposcopy clinic. J Am Med Assoc 1988;260:2214-5.
7. Centers for Disease Control and Prevention: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 1992;41:1-19.
8. Schrager LK, Friedland GH, Maude D et al. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol 1989;2:570-575.
9. Schafer, Friedland W, Mielke H et al. Increased frequency of cervical dysplasia/neoplasia in HIV-infected women is related to the extent of immunosuppression. Am J Obstet Gynecol 1991;164:593-599.
10. Vermund SH, Kelley KF, Klein RS et al. High risk of human papillomavirus infection and squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1992;165:392-400.
11. Mandelblatt JS, Fahs M, Garibaldi K et al. Association between HIV infection and cervical neoplasia: Implications for clinical care of women at risk for both conditions. AIDS 1992; 6:173-178.
12. Wright TC, Ellerbrock TV, Chiasson MA et al. CIN in women infected with HIV: Prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994;591-597.
13. Del Priore G, Maag T, Bhattacharya M et al. The value of cervical cytology in HIV-infected women. Gynecol Oncol 1995;56:395-398.
14. Fink MJ, Fruchter RG, Maiman M et al. The adequacy of cytology and colposcopy in diagnosing cervical neoplasia in HIV-seropositive women. Gynecol Oncol 1994;55:133-137.
15. Murphy M, Pomeroy L, Tynan M et al. Cervical cytological screening in HIV-infected women in Dublin - A six-year review. Int J STD AIDS 1995;6:262-266.
16. Branca M, Delfino A, Rossi E et al. Cervical intraepithelial neoplasia and human papillomavirus-related lesions of the genital tract in HIV-positive and -negative women. Eur J Gynaecol Oncol 1995;16:410-417.
17. Korn AP, Autry M, DeRemer PA et al. Sensitivity of the Papanicolaou smear in human immunodeficiency virus-infected women. Obstet Gynecol 1994;83:401-404.
18. Drapkin AL, Livingston EG, Dodge R et al. Cervical intraepithelial neoplasia in HIV-infected women in a southeastern U.S. population. South Med J 1997;90:893-896.
19. Petry KU, Scheffel D, Bode U et al. Cellular immunodeficiency enhances progression of human papillomavirus-associated cervical lesions. Int J Cancer 1994;57:836-840.
20. Schafer A, Friedmann W, Mielke M et al. The increased frequency of cervical dysplasia-neoplasia in women infected with human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991;164:593-599.
21. Johnson JC, Burnett AF, Willet GD et al. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 1992;79:321-327.
22. Maiman M, Fruchter RG, Serur E et al. Colposcopic evaluation of human immunodeficiency virus seropositive women. Obstet Gynecol 1991;78:84-88.
23. Klein RS, Ho GYF, Vermund SH et al. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficency virus infection. J Infect Dis 1994; 170:1404-1409.
24. Spinillo A, Tenti P, Zappatore R et al. Langerhans cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection. Gynecol Oncol 1993;48: 210-213.
25. Rosini S, Catagirone S, Tallini G et al. Depletion of stromal and intraepithelial antigen-presenting cells in cervical neoplasia in human immunodeficiency virus infection. Hum Pathol 1996; 27:834-838.
26. Sun XW, Ellerbrock TV, Lungu O et al. Human papillomavirus infection in human immunodeficiency virus seropositive women. Obstet Gynecol 1995;85:680-686.
27. Maiman M, Fruchter RG, Serur E et al. Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol 1990;38:377-382.
28. Smith JR, Kitchen VS, Butcherby M et al. Is HIV infection associated with an increase in the prevalence of cervical neoplasia. Br J Obstet Gynaecol 1993;100:149-153.
29. Boardman LA, Peipert JF, Cooper AS et al. Cytologic-histologic discrepancy in human immunodeficiency virus-positive women referred to a colposcopy clinic. Obstet Gynecol 1994;84:1016-1020.
30. Strigle SM, Walts AE. Underutilization of the Papanicolaou smear in human immunodeficiency virus-positive women. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:206.
31. Wright TC, Moscarelli RD, Dole P et al. Significance of mild cytologic atypia in women infected with human immunodefi-ciency virus. Obstet Gynecol 1996;87:515-519.
32. Heard I, Bergeron C, Jeannel D et al. Papanicolaou smears in human immunodeficiency virus seropositive women during follow-up. Gynecol Oncol 1995;86:749-753.
33. Belafsky P, Clark RA, Kissinger P et al. Natural history of low grade squamous intraepithelial lesions in women infected with human papillomavirus virus. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:511-512.
34. Conti M. Prevalence and risk of progression of genital intraepithelial neoplasia in women with human immunodeficiency virus infection. Adv Gynecol Obstet Res 1991;3:283-287.
35. Sun XW, Kuhn L, Ellerbrock TV et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-1349.
36. Maiman M, Fruchter RG, Serur E et al. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 1993;82:170-174.
37. Sillman FH, Sedlis A, Boyce JG. A review of lower genital intraepithelial neoplasia and the use of tropical 5-fluorouracil. Obstet Gynecol Surv 1985;40:190-200.
38. Fruchter RG, Maiman M, Sedlis A et al. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996;87:338-344.
39. Wright TC, Koulos J, Schnoll F et al. Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: Outcome after loop electrosurgical excision. Gynecol Oncol 1994;55:253-258.
40. Cuthill S, Maiman M, Fruchter RG et al. Complications after treatment of cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. J Reprod Med 1995;40:823-828.
41. Yliskoski M, Cantell K, Syrjanen K et al. Topical treatment with human leukocyte interferon of HPV-16 infections associated with cervical and vaginal intraepithelial neoplasias. Gynecol Oncol 1990;36:353-357.
42. Maiman M, Fruchter R. Cervical neoplasia and the human immunodeficiency virus. In: Rubin SC, Hoskins WJ, eds. Cervical cancer and preinvasive neoplasia. Philadelphia: Lippincott-Raven Publishers, 1996, pp 405-416.
43. Wakeman R, Johnson CD, Wastell C. Surgical procedures in patients at risk of human immunodeficiency virus infection. J R Soc Med 1990;83:315-318.
44. Burke EC, Orloff SL, Freise CE et al. Wound healing after anorectal surgery in HIV-infected patients. Arch Surg 1991; 1267-1271.
45. Adachi A, Fleming I, Burk RD et al. Women with human immunodeficiency virus infection and abnormal Pap smears: A prospective study of colposcopy and clinical outcome. Obstet Gynecol 1993;81:372-377.
46. Fruchter RG, Maiman M, Sillman FH et al. Characteristics of cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus. Am J Obstet Gynecol 1994; 171:531-537.
47. Byrne MA, Taylor-Robinson D, Munday PE et al. The common occurrence of human papillomavirus infection and intraepithelial neoplasia in women infected by HIV. AIDS 1989;3:379-382.
48. Korn AP, Abercrombie PD, Foster A. Vulvar intraepithelial neoplasia in women infected with human immunodeficiency virus-1. Gynecol Oncol 1996;61:384-386.
49. Petry KU, Kochel H, Bode U et al. Human papillomavirus is associated with the frequent detection of warty and basaloid high-grade neoplasia of the vulva and cervical neoplasia among immunocompromised women. Gynecol Oncol 1996; 60:30-34.
50. Chiasson MA, Ellerbrock TV, Bush TJ et al. Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus. Obstet Gynecol 1997;89:690-694.
51. Penn I. Cancers of the anogenital region in renal transplant recipients. Cancer 1986;58:611-616.